Telix Pharmaceuticals Ltd (TLX) stock
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.86−0.06 (-0.73%)
Close on Nov 17, 2026Market cap $3.00BP/E –Yield –
Telix Pharmaceuticals EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Telix Pharmaceuticals's EV/EBITDA was 69.4× on Nov 11, 2026, against 55.4× a year earlier. Over the last 2 years it ranged from 40.1× to 392.0×, with a median of 76.2×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 69.4× | +28.0 |
| 2025 | Dec 31, 2025 | 41.3× | −282.3 |
| 2024 | Dec 31, 2024 | 323.6× | – |
See a number that looks wrong?